[(89)Zr]-Atezolizumab-PET Imaging Reveals Longitudinal Alterations in PDL1 during Therapy in TNBC Preclinical Models

SIMPLE SUMMARY: Triple-negative breast cancer is characterized by a lack of targetable treatment receptors and current standard of care options, such as radiation therapy and chemotherapy, are associated with acute patient toxicity. Noninvasive imaging of PD-L1, with [(89)Zr]-Atezolizumab-PET imagin...

Descripción completa

Detalles Bibliográficos
Autores principales: Massicano, Adriana V. F., Song, Patrick N., Mansur, Ameer, White, Sharon L., Sorace, Anna G., Lapi, Suzanne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216761/
https://www.ncbi.nlm.nih.gov/pubmed/37345044
http://dx.doi.org/10.3390/cancers15102708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216761/
https://www.ncbi.nlm.nih.gov/pubmed/37345044
http://dx.doi.org/10.3390/cancers15102708

Ejemplares similares